The actin-binding protein EPS8 binds VE-cadherin and modulates YAP localization and signaling

Journal of Cell Biology

Volumn 211, Issue 6, 2015, Pages 1177-1192

  Giampietro, Costanza ^a,e   Disanza, Andrea ^a   Bravi, Luca ^a   Barrios Rodiles, Miriam ^b   Corada, Monica ^a   Frittoli, Emanuela ^a   Savorani, Cecilia ^a   Lampugnani, Maria Grazia ^a,f   Boggetti, Barbara ^d   Niessen, Carien ^d   Wrana, JeffL ^b,c   Scita, Giorgio ^a,e   Dejana, Elisabetta ^a,e,g  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF MILAN   (Italy)

^f MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ACTIN BINDING PROTEIN EPS8; ALPHA CATENIN; EPS8 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN 14 3 3; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; YES ASSOCIATED PROTEIN; CADHERIN; EPS8 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; PHOSPHOPROTEIN; PROTEIN BINDING; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YAP PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL JUNCTION; CONTACT INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; BINDING SITE; C57BL MOUSE; CELL LINE; DEFICIENCY; KNOCKOUT MOUSE; METABOLISM; PROTEIN TRANSPORT; VASCULAR ENDOTHELIUM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD; BINDING SITES; CADHERINS; CELL LINE; ENDOTHELIUM, VASCULAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 84959483815     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201501089     Document Type: Article

References (55)

1. Aragona, M., T. Panciera, A. Manfrin, S. Giulitti, F. Michielin, N. Elvassore, S. Dupont, and S. Piccolo. 2013. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell. 154:1047-1059. http://dx.doi.org/10.1016/j.cell.2013.07.042
2. Auciello, G., D.L. Cunningham, T. Tatar, J.K. Heath, and J.Z. Rappoport. 2013. Regulation of fibroblast growth factor receptor signalling and trafficking by Src and Eps8. J. Cell Sci. 126:613-624. http://dx.doi.org/10.1242/jcs.116228
3. Balconi, G., R. Spagnuolo, and E. Dejana. 2000. Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro. Arterioscler. Thromb. Vasc. Biol. 20:1443-1451. http://dx.doi.org/10.1161/01.ATV.20.6.1443
4. Barrios-Rodiles, M., K.R. Brown, B. Ozdamar, R. Bose, Z. Liu, R.S. Donovan, F. Shinjo, Y. Liu, J. Dembowy, I.W. Taylor, et al. 2005. High-throughput mapping of a dynamic signaling network in mammalian cells. Science. 307:1621-1625. http://dx.doi.org/10.1126/science.1105776
5. Basu, S., N.F. Totty, M.S. Irwin, M. Sudol, and J. Downward. 2003. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell. 11:11-23. http://dx.doi.org/10.1016/S1097-2765(02)00776-1
6. Brown, D.J., E.M. Rzucidlo, B.L. Merenick, R.J. Wagner, K.A. Martin, and R.J. Powell. 2005. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation. J. Vasc. Surg. 41:509-516. http://dx.doi.org/10.1016/j.jvs.2004.12.024
7. Carmeliet, P., M.G. Lampugnani, L. Moons, F. Breviario, V. Compernolle, F. Bono, G. Balconi, R. Spagnuolo, B. Oosthuyse, M. Dewerchin, et al. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 98:147-157. http://dx.doi.org/10.1016/S0092-8674(00)81010-7
8. Caveda, L., I. Martin-Padura, P. Navarro, F. Breviario, M. Corada, D. Gulino, M.G. Lampugnani, and E. Dejana. 1996. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). J. Clin. Invest. 98:886-893. http://dx.doi.org/10.1172/JCI118870
9. Choi, H.J., H. Zhang, H. Park, K.S. Choi, H.W. Lee, V. Agrawal, Y.M. Kim, and Y.G. Kwon. 2015. Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2. Nat. Commun. 6:6943. http://dx.doi.org/10.1038/ncomms7943
10. Corada, M., L. Zanetta, F. Orsenigo, F. Breviario, M.G. Lampugnani, S. Bernasconi, F. Liao, D.J. Hicklin, P. Bohlen, and E. Dejana. 2002. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood. 100:905-911. http://dx.doi.org/10.1182/blood. V100.3.905
11. Croce, A., G. Cassata, A. Disanza, M.C. Gagliani, C. Tacchetti, M.G. Malabarba, M.F. Carlier, G. Scita, R. Baumeister, and P.P. Di Fiore. 2004. A novel actin barbed-end-capping activity in EPS-8 regulates apical morphogenesis in intestinal cells of Caenorhabditis elegans. Nat. Cell Biol. 6:1173-1179. http://dx.doi.org/10.1038/ncb1198
12. Dejana, E., and C. Giampietro. 2012. Vascular endothelial-cadherin and vascular stability. Curr. Opin. Hematol. 19:218-223. http://dx.doi.org/10.1097/MOH.0b013e3283523e1c
13. Dejana, E., and D. Vestweber. 2013. The role of VE-cadherin in vascular morphogenesis and permeability control. Prog. Mol. Biol. Transl. Sci. 116:119-144. http://dx.doi.org/10.1016/B978-0-12-394311-8.00006-6
14. Dejana, E., E. Tournier-Lasserve, and B.M. Weinstein. 2009. The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications. Dev. Cell. 16:209-221. http://dx.doi.org/10.1016/j.devcel.2009.01.004
15. Di Fiore, P.P., and G. Scita. 2002. Eps8 in the midst of GTPases. Int. J. Biochem. Cell Biol. 34:1178-1183. http://dx.doi.org/10.1016/S1357-2725(02)00064-X
16. Disanza, A., M.F. Carlier, T.E. Stradal, D. Didry, E. Frittoli, S. Confalonieri, A. Croce, J. Wehland, P.P. Di Fiore, and G. Scita. 2004. Eps8 controls actin-based motility by capping the barbed ends of actin filaments. Nat. Cell Biol. 6:1180-1188. http://dx.doi.org/10.1038/ncb1199
17. Disanza, A., S. Mantoani, M. Hertzog, S. Gerboth, E. Frittoli, A. Steffen, K. Berhoerster, H.J. Kreienkamp, F. Milanesi, P.P. Di Fiore, et al. 2006. Regulation of cell shape by Cdc42 is mediated by the synergic actinbundling activity of the Eps8-IRSp53 complex. Nat. Cell Biol. 8:1337-1347. http://dx.doi.org/10.1038/ncb1502
18. Disanza, A., S. Bisi, M. Winterhoff, F. Milanesi, D.S. Ushakov, D. Kast, P. Marighetti, G. Romet-Lemonne, H.M. Müller, W. Nickel, et al. 2013. CDC42 switches IRSp53 from inhibition of actin growth to elongation by clustering of VASP. EMBO J. 32:2735-2750. http://dx.doi.org/10.1038/emboj.2013.208
19. Dong, Q.G., S. Bernasconi, S. Lostaglio, R.W. De Calmanovici, I. Martin-Padura, F. Breviario, C. Garlanda, S. Ramponi, A. Mantovani, and A. Vecchi. 1997. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler. Thromb. Vasc. Biol. 17:1599-1604. http://dx.doi.org/10.1161/01.ATV.17.8.1599
20. Dupont, S., L. Morsut, M. Aragona, E. Enzo, S. Giulitti, M. Cordenonsi, F. Zanconato, J. Le Digabel, M. Forcato, S. Bicciato, et al. 2011. Role of YAP/TAZ in mechanotransduction. Nature. 474:179-183. http://dx.doi.org/10.1038/nature10137
21. Frittoli, E., G. Matteoli, A. Palamidessi, E. Mazzini, L. Maddaluno, A. Disanza, C. Yang, T. Svitkina, M. Rescigno, and G. Scita. 2011. The signaling adaptor Eps8 is an essential actin capping protein for dendritic cell migration. Immunity. 35:388-399. http://dx.doi.org/10.1016/j.immuni.2011.07.007
22. Gavard, J., and J.S. Gutkind. 2006. VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 8:1223-1234. http://dx.doi.org/10.1038/ncb1486
23. Giampietro, C., A. Taddei, M. Corada, G.M. Sarra-Ferraris, M. Alcalay, U. Cavallaro, F. Orsenigo, M.G. Lampugnani, and E. Dejana. 2012. Overlapping and divergent signaling pathways of N-cadherin and VEcadherin in endothelial cells. Blood. 119:2159-2170. http://dx.doi.org/10.1182/blood -2011-09-381012
24. Giannotta, M., M. Trani, and E. Dejana. 2013. VE-cadherin and endothelial adherens junctions: Active guardians of vascular integrity. Dev. Cell. 26:441-454. http://dx.doi.org/10.1016/j.devcel.2013.08.020
25. Goddard, L.M., and M.L. Iruela-Arispe. 2013. Cellular and molecular regulation of vascular permeability. Thromb. Haemost. 109:407-415. http://dx.doi.org/10.1160/TH12-09-0678
26. Hertzog, M., F. Milanesi, L. Hazelwood, A. Disanza, H. Liu, E. Perlade, M.G. Malabarba, S. Pasqualato, A. Maiolica, S. Confalonieri, et al. 2010. Molecular basis for the dual function of Eps8 on actin dynamics:Bundling and capping. PLoS Biol. 8:e1000387. http://dx.doi.org/10.1371/journal.pbio.1000387
27. Kim, N.G., E. Koh, X. Chen, and B.M. Gumbiner. 2011. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc. Natl. Acad. Sci. USA. 108:11930-11935. http://dx.doi.org/10.1073/pnas.1103345108
28. Kluger, M.S., P.R. Clark, G. Tellides, V. Gerke, and J.S. Pober. 2013. Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 33:489-500. http://dx.doi.org/10.1161/ATV BAHA.112.300893
29. Lampugnani, M.G., M. Corada, P. Andriopoulou, S. Esser, W. Risau, and E. Dejana. 1997. Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J. Cell Sci. 110:2065-2077.
30. Lanzetti, L., V. Rybin, M.G. Malabarba, S. Christoforidis, G. Scita, M. Zerial, and P.P. Di Fiore. 2000. The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. Nature. 408:374-377. http://dx.doi.org/10.1038/35042605
31. Levéen, P., M. Pekny, S. Gebre-Medhin, B. Swolin, E. Larsson, and C. Betsholtz. 1994. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8:1875-1887. http://dx.doi.org/10.1101/gad.8.16.1875
32. Manor, U., A. Disanza, M. Grati, L. Andrade, H. Lin, P.P. Di Fiore, G. Scita, and B. Kachar. 2011. Regulation of stereocilia length by myosin XVa and whirlin depends on the actin-regulatory protein Eps8. Curr. Biol. 21:167-172. http://dx.doi.org/10.1016/j.cub.2010.12.046
33. McCrea, P.D., D. Gu, and M.S. Balda. 2009. Junctional music that the nucleus hears: Cell-cell contact signaling and the modulation of gene activity. Cold Spring Harb. Perspect. Biol. 1:a002923. http://dx.doi.org/10.1101/cshperspect.a002923
34. Menna, E., A. Disanza, C. Cagnoli, U. Schenk, G. Gelsomino, E. Frittoli, M. Hertzog, N. Offenhauser, C. Sawallisch, H.J. Kreienkamp, et al. 2009. Eps8 regulates axonal filopodia in hippocampal neurons in response to brain-derived neurotrophic factor (BDNF). PLoS Biol. 7:e1000138. http://dx.doi.org/10.1371/journal.pbio.1000138
35. Miller, B.W., G. Lau, C. Grouios, E. Mollica, M. Barrios-Rodiles, Y. Liu, A. Datti, Q. Morris, J.L. Wrana, and L. Attisano. 2009. Application of an integrated physical and functional screening approach to identify inhibitors of the Wnt pathway. Mol. Syst. Biol. 5:315. http://dx.doi.org/10.1038/msb.2009.72
36. Morgan, J.T., C.J. Murphy, and P. Russell. 2013. What do mechanotransduction, Hippo, Wnt, and TGFβ have in common? YAP and TAZ as key orchestrating molecules in ocular health and disease. Exp. Eye Res. 115:1-12. http://dx.doi.org/10.1016/j.exer.2013.06.012
37. Morin-Kensicki, E.M., B.N. Boone, M. Howell, J.R. Stonebraker, J. Teed, J.G. Alb, T.R. Magnuson, W. O'Neal, and S.L. Milgram. 2006. Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol. Cell. Biol. 26:77-87. http://dx.doi.org/10.1128/MCB.26.1.77-87.2006
38. Muslin, A.J., and H. Xing. 2000. 14-3-3 proteins: Regulation of subcellular localization by molecular interference. Cell. Signal. 12:703-709. http://dx.doi.org/10.1016/S0898-6568(00)00131-5
39. Navarro, P., L. Caveda, F. Breviario, I. Mândoteanu, M.G. Lampugnani, and E. Dejana. 1995. Catenin-dependent and -independent functions of vascular endothelial cadherin. J. Biol. Chem. 270:30965-30972. http://dx.doi.org/10.1074/jbc.270.52.30965
40. Orsenigo, F., C. Giampietro, A. Ferrari, M. Corada, A. Galaup, S. Sigismund, G. Ristagno, L. Maddaluno, G.Y. Koh, D. Franco, et al. 2012. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat. Commun. 3:1208. http://dx.doi.org/10.1038/ncomms2199
41. Pannekoek, W.J., J.J. van Dijk, O.Y. Chan, S. Huveneers, J.R. Linnemann, E. Spanjaard, P.M. Brouwer, A.J. van der Meer, F.J. Zwartkruis, H. Rehmann, et al. 2011. Epac1 and PDZ-GEF cooperate in Rap1 mediated endothelial junction control. Cell. Signal. 23:2056-2064. http://dx.doi.org/10.1016/j.cellsig.2011.07.022
42. Ribatti, D., B. Nico, A. Vacca, L. Roncali, and F. Dammacco. 2002. Endothelial cell heterogeneity and organ specificity. J. Hematother. Stem Cell Res. 11:81-90. http://dx.doi.org/10.1089/152581602753448559
43. Schlegelmilch, K., M. Mohseni, O. Kirak, J. Pruszak, J.R. Rodriguez, D. Zhou, B.T. Kreger, V. Vasioukhin, J. Avruch, T.R. Brummelkamp, and F.D. Camargo. 2011. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell. 144:782-795. http://dx.doi.org/10.1016/j.cell.2011.02.031
44. Scita, G., J. Nordstrom, R. Carbone, P. Tenca, G. Giardina, S. Gutkind, M. Bjarnegård, C. Betsholtz, and P.P. Di Fiore. 1999. EPS8 and E3B1 transduce signals from Ras to Rac. Nature. 401:290-293. http://dx.doi.org/10.1038/45822
45. Silvis, M.R., B.T. Kreger, W.H. Lien, O. Klezovitch, G.M. Rudakova, F.D. Camargo, D.M. Lantz, J.T. Seykora, and V. Vasioukhin. 2011. α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci. Signal. 4:ra33.
46. Spagnuolo, R., M. Corada, F. Orsenigo, L. Zanetta, U. Deuschle, P. Sandy, C. Schneider, C.J. Drake, F. Breviario, and E. Dejana. 2004. Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis. Blood. 103:3005-3012. http://dx.doi.org/10.1182/blood -2003-07-2459
47. Taddei, A., C. Giampietro, A. Conti, F. Orsenigo, F. Breviario, V. Pirazzoli, M. Potente, C. Daly, S. Dimmeler, and E. Dejana. 2008. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat. Cell Biol. 10:923-934. http://dx.doi.org/10.1038/ncb1752
48. Taylor, M.J., E.R. Tiangga, R.N. Mhuircheartaigh, and P.J. Cowen. 2012. Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: A proton magnetic resonance spectroscopy study. J. Psychopharmacol. (Oxford). 26:733-737. http://dx.doi.org/10.1177/0269881111405359
49. Tocchetti, A., C.B. Soppo, F. Zani, F. Bianchi, M.C. Gagliani, B. Pozzi, J. Rozman, R. Elvert, N. Ehrhardt, B. Rathkolb, et al. 2010. Loss of the actin remodeler Eps8 causes intestinal defects and improved metabolic status in mice. PLoS One. 5:e9468. http://dx.doi.org/10.1371/journal.pone.0009468
50. Vandenbroucke, E., D. Mehta, R. Minshall, and A.B. Malik. 2008. Regulation of endothelial junctional permeability. Ann. N.Y. Acad. Sci. 1123:134-145. http://dx.doi.org/10.1196/annals.1420.016
51. Varelas, X. 2014. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development. 141:1614-1626. http://dx.doi.org/10.1242/dev.102376
52. Vestweber, D., M. Winderlich, G. Cagna, and A.F. Nottebaum. 2009. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol. 19:8-15. http://dx.doi.org/10.1016/j.tcb.2008.10.001
53. Vestweber, D., A. Broermann, and D. Schulte. 2010. Control of endothelial barrier function by regulating vascular endothelial-cadherin. Curr. Opin. Hematol. 17:230-236. http://dx.doi.org/10.1097/MOH.0b013e328338664b
54. Zhao, B., X. Wei, W. Li, R.S. Udan, Q. Yang, J. Kim, J. Xie, T. Ikenoue, J. Yu, L. Li, et al. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21:2747-2761. http://dx.doi.org/10.1101/gad.1602907
55. Zhao, B., K. Tumaneng, and K.L. Guan. 2011. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 13:877-883. http://dx.doi.org/10.1038/ncb2303